Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals

Apoptosis has been suggested as one of the major mechanisms of CD4+ T cell depletion during the course of HIV type 1 (HIV-1) infection. Here, we show that interleukin 7 (IL-7), a nonredundant cytokine that plays essential roles in the generation and homeostasis of the T cell compartment of the immune system, exerts strong antiapoptotic effects ex vivo on both CD4+ and CD8+ T cells derived from HIV-1-infected subjects. The level of IL-7-mediated reduction of apoptosis was inversely correlated with the number of circulating CD4+ T cells, indicating a higher sensitivity to IL-7 effects in patients with more advanced disease. The antiapoptotic effect of IL-7 was uncoupled from the induction of cellular proliferation or endogenous HIV-1 replication. These results provide a further rationale for consideration of IL-7 as an agent of immune reconstitution in HIV-1 infection.

[1]  J. Barretina,et al.  Interleukin-7 in Plasma Correlates with CD4 T-Cell Depletion and May Be Associated with Emergence of Syncytium-Inducing Variants in Human Immunodeficiency Virus Type 1-Positive Individuals , 2001, Journal of Virology.

[2]  B. Assouline,et al.  Recombinant Interleukin-7 Induces Proliferation of Naive Macaque CD4+ and CD8+ T Cells In Vivo , 2004, Journal of Virology.

[3]  K. Muegge,et al.  The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. , 1998, Journal of immunology.

[4]  R. Grant,et al.  Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis , 2001, Nature Medicine.

[5]  C. Cicala,et al.  HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Fry,et al.  The Many Faces of IL-7: From Lymphopoiesis to Peripheral T Cell Maintenance , 2005, The Journal of Immunology.

[7]  F. Barré-Sinoussi,et al.  IL-7 Stimulates T Cell Renewal Without Increasing Viral Replication in Simian Immunodeficiency Virus-Infected Macaques 1 , 2003, The Journal of Immunology.

[8]  P. Paoli,et al.  Effects of therapy with highly active anti‐retroviral therapy (HAART) and IL‐2on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patients , 2000, Clinical and experimental immunology.

[9]  F. Barré-Sinoussi,et al.  Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Fauci,et al.  Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. , 1995, Journal of immunology.

[11]  R. Cheynier,et al.  IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy1 , 2006, The Journal of Immunology.

[12]  J. Estaquier,et al.  Caspase-dependent and -independent T-cell death pathways in pathogenic simian immunodeficiency virus infection: relationship to disease progression , 2003, Cell Death and Differentiation.

[13]  M. Lederman,et al.  Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection. , 2003, The Journal of antimicrobial chemotherapy.

[14]  Y. Adachi,et al.  IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2. , 1996, Journal of immunology.

[15]  H. Petry,et al.  T cell apoptosis in human immunodeficiency virus type 2- and simian immunodeficiency virus-infected macaques. , 1996, The Journal of general virology.

[16]  C. Rapp,et al.  Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3. , 2002, Blood.

[17]  D. Douek,et al.  IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. , 2003, Blood.

[18]  J. Estaquier,et al.  HIV-1 triggers mitochondrion death. , 2004, Mitochondrion.

[19]  E. Vittinghoff,et al.  Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors. , 1998, The Journal of infectious diseases.

[20]  L. Montagnier,et al.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. , 1996, Journal of immunology.

[21]  R. Koup,et al.  T cell dynamics in HIV-1 infection. , 2003, Annual review of immunology.

[22]  J. Heeney,et al.  Programmed cell death in AIDS-related HIV and SIV infections. , 1993, AIDS research and human retroviruses.

[23]  S. Patterson,et al.  Antigen presentation and the role of dendritic cells in HIV , 2004, Current opinion in infectious diseases.

[24]  C. Chuang,et al.  Preliminary treatment results of intensity-modulated radiotherapy for prostate cancer. , 2006, Chang Gung medical journal.

[25]  A. Capron,et al.  Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals , 1992, The Journal of experimental medicine.

[26]  N. Haigwood,et al.  Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis , 1992, The Journal of experimental medicine.

[27]  J. Torres-Roca,et al.  Interleukin-1β Converting Enzyme–like Protease Involvement in Fas-induced and Activation-induced Peripheral Blood T Cell Apoptosis in HIV Infection. TNF-related Apoptosis-inducing Ligand Can Mediate Activation-induced T Cell Death in HIV Infection , 1997, The Journal of experimental medicine.

[28]  J. Angel,et al.  Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. , 2001, Journal of acquired immune deficiency syndromes.

[29]  F. Chiodi,et al.  Loss of IL-7Rα is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients , 2005, AIDS.

[30]  A. MacGowan,et al.  Development of the quinolones. , 2003, The Journal of antimicrobial chemotherapy.

[31]  A. Khaled,et al.  Death and Baxes: mechanisms of lymphotrophic cytokines , 2003, Immunological reviews.

[32]  O. Lambotte,et al.  Regulatory Dysfunction of the Interleukin-7 Receptor in CD4 and CD8 Lymphocytes From HIV-Infected Patients-Effects of Antiretroviral Therapy , 2006, Journal of acquired immune deficiency syndromes.

[33]  O. Haffar,et al.  IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. , 1996, Journal of immunology.

[34]  J. Corbeil,et al.  Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2. , 2003, The Journal of infectious diseases.

[35]  R. Cattaneo,et al.  Study of spontaneous apoptosis in HIV+ patients: correlation with clinical progression and T cell loss. , 1997, AIDS research and human retroviruses.

[36]  T. Curiel,et al.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes , 1995, Nature Medicine.

[37]  E. Bosmans,et al.  Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. , 1998, Immunology letters.

[38]  M. Thomson,et al.  IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. , 2005, The Journal of clinical investigation.

[39]  J. Metcalf,et al.  Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. , 1996, The New England journal of medicine.